You may also like
Factor XI Inhibition to Uncouple Thrombosis From Hemostasis: JACC Review Topic of the Week
The authors provide a visual representation of the coagulation pathways that distinguishes between the steps involved in thrombosis and hemostasis to explain why factor XI inhibitors may serve as hemostasis-sparing anticoagulants. A safer class of anticoagulants would provide opportunities for treatment of a wider range of patients, including those at high risk for bleeding. Ongoing clinical studies will determine the extent to which factor XI inhibitors attenuate thrombosis without disruption of hemostasis.
Outcomes of Surgical Aortic Valve Replacement: The Benchmark for Percutaneous Therapies
This article will discuss current outcomes for surgical aortic valve replacement (SAVR) among high- and intermediate-risk patients with aortic valve stenosis (AS) as a barometer in assessing the results of nascent percutaneous therapies.
Cardiac Computed Tomography and Computed Tomography Angiography in the Evaluation of Patients Prior to Transcatheter Aortic Valve Implantation
The purpose of this review is to provide an up-to-date review of recently published data, with a particular focus on annular sizing and transcatheter heart valve selection to help reduce paravalvular regurgitation.
